BHVNBiohaven Ltd.

$1B

Q2 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$94M

Net Income

-$90M

EPS (Diluted)

$-1.32

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$44M

Free Cash Flow

-$45M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$507M

Total Liabilities

$119M

Stockholders' Equity

$387M

Cash & Equivalents

$148M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$94M	-$197M	+52.3%
Net Income	-$90M	-$203M	+55.6%

BHVN Q2 2023 Earnings — Biohaven Ltd. Revenue & Financial Results | Market Cap Arena